Whether you're looking to boost energy, enhance recovery, or support your immune system, we have an IV drip designed for you
Until clinical trials are completed, FDA review is finalized, and legal prescribing pathways are established, there is no legitimate retail supply of retatrutide available to consumers
[8] Buch, A., Yeshurun, S., Cramer, T., Baumann, A., Sencelsky, Y., Zelber Sagi, S., Serebro, M., Greenman, Y., Mor, M., & Eldor, R
GLP-3 (Reta) is not currently named on the WADA 2026 Prohibited List
Finally, the increasing off-label use of GLP-1 RAs for weight loss in non-diabetic individuals may further exacerbate access limitations and drug shortages, potentially disadvantaging patients with T2DM